keyword
https://read.qxmd.com/read/36329790/the-potential-of-mir-153-as-aggressive-prostate-cancer-biomarker
#21
JOURNAL ARTICLE
Irina Gilyazova, Elizaveta Ivanova, Mikhail Sinelnikov, Valentin Pavlov, Elza Khusnutdinova, Ilgiz Gareev, Aferin Beilerli, Ludmila Mikhaleva, Yanchao Liang
Introduction: Prostate cancer (PC) is one of the most frequently diagnosed cancers in males. MiR-153, as a member of the microRNA (miRNA) family, plays an important role in PC. This study aims to explore the expression and possible molecular mechanisms of the miR-153 action. Methods: Formalin-fixed paraffin-embedded (FFPE) tissues were collected from prostatectomy specimens of 29 metastatic and 32 initial stage PC patients. Expression levels of miR-153 were measured using real-time reverse transcription polymerase chain reaction (qRT-PCR)...
March 2023: Non-Coding RNA Research
https://read.qxmd.com/read/36230789/glycosaminoglycan-analysis-of-ffpe-tissues-from-prostate-cancer-and-benign-prostate-hyperplasia-patients-reveals-altered-regulatory-functions-and-independent-markers-for-survival
#22
JOURNAL ARTICLE
Gábor Tóth, Simon Sugár, Domonkos Pál, Kata Dorina Fügedi, László Drahos, Gitta Schlosser, Csilla Oláh, Henning Reis, Ilona Kovalszky, Tibor Szarvas, Lilla Turiák
Prostate cancer is one of the most frequent cancer types among men. Several biomarkers and risk assessment methods are already available; however, enhancing their selectivity and sensitivity is still necessary. For improving therapeutic decisions, both basic and clinical research studies are still ongoing for a better understanding of the underlying molecular mechanisms. The enzymatic digests of heparan sulfate (HS) and chondroitin sulfate (CS) chains were investigated in tissue samples taken from patients with prostate cancer (PCa) and benign prostate hyperplasia (BPH) with the HPLC-MS methodology...
October 5, 2022: Cancers
https://read.qxmd.com/read/35954429/proteomic-analysis-of-prostate-cancer-ffpe-samples-reveals-markers-of-disease-progression-and-aggressiveness
#23
JOURNAL ARTICLE
Vasiliki Lygirou, Konstantinos Fasoulakis, Rafael Stroggilos, Manousos Makridakis, Agnieszka Latosinska, Maria Frantzi, Ioannis Katafigiotis, Christos Alamanis, Konstantinos G Stravodimos, Constantinos A Constantinides, Antonia Vlahou, Jerome Zoidakis
Prostate cancer (PCa) is the second most common cancer in men. Diagnosis and risk assessment are widely based on serum Prostate Specific Antigen (PSA) and biopsy, which might not represent the exact degree of PCa risk. Towards the discovery of biomarkers for better patient stratification, we performed proteomic analysis of Formalin Fixed Paraffin Embedded (FFPE) prostate tissue specimens using liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Comparative analysis of 86 PCa samples among grade groups 1-5 identified 301 significantly altered proteins...
August 2, 2022: Cancers
https://read.qxmd.com/read/35805010/genotype-to-phenotype-associations-in-the-aggressive-variant-prostate-cancer-molecular-profile-avpc-m-components
#24
JOURNAL ARTICLE
Rama Soundararajan, Paul Viscuse, Patrick Pilie, Jingjing Liu, Souzana Logotheti, Caddie Laberiano Fernández, Daniele Lorenzini, Anh Hoang, Wei Lu, Luisa Maren Solis Soto, Ignacio I Wistuba, Mingchu Xu, Xingzhi Song, Peter D A Shepherd, Nora M Navone, Rebecca S S Tidwell, Guillermina Lozano, Christopher Logothetis, Jianhua Zhang, James P Long, Marcos R Estecio, Vasiliki Tzelepi, Ana M Aparicio
The aggressive variant prostate cancer molecular profile (AVPC-m), composed of combined defects in TP53, RB1 and PTEN, characterizes a subset of prostate cancers linked to androgen indifference and platinum sensitivity. To contribute to the optimization of the AVPC-m assessment for inclusion in prospective clinical trials, we investigated the status of the AVPC-m components in 28 patient tumor-derived xenografts (PDXs) developed at MDACC. We subjected single formalin-fixed, paraffin-embedded (FFPE) blocks from each PDX to immunohistochemistry (IHC), targeted next-generation genomic sequencing (NGS) and Clariom-S Affymetrix human microarray expression profiling...
June 30, 2022: Cancers
https://read.qxmd.com/read/35787794/validation-of-a-dna-based-next-generation-sequencing-test-for-molecular-diagnostic-variant-and-fusion-detection-in-formalin-fixed-paraffin-embedded-tissue-specimens-and-liquid-biopsy-plasma-cell-free-dna-samples
#25
JOURNAL ARTICLE
Tamara V Werner, Sylvia Kock, Isabel Weber, Gian Kayser, Martin Werner, Silke Lassmann
This study evaluated two DNA-based next-generation sequencing approaches for detection of single-nucleotide variants (SNVs) and fusions in formalin-fixed, paraffin-embedded (FFPE) tissue specimens and liquid biopsies (AVENIO Targeted and Surveillance Panels). Reference standards (n = 7 with SNVs and structural variants) and real-world FFPE tissue specimens (n = 26 lung, colorectal, pancreas, ovary, breast, prostate, melanoma, and soft tissue cancer cases with n = 27 samples), liquid biopsies [n = 29 cases with n = 40 plasma/cell-free DNA (cfDNA) samples], and one pleural effusion (lung cancer) were analyzed by the AVENIO workflow for known SNVs (BRAF, BRCA1/2, CTNNB1, EGFR, KRAS, MET exon 14 skipping, NRAS, PIK3CA, and TP53), insertions and deletions (ERBB2 and KIT), and fusions (ALK and ROS1)...
July 2022: Journal of Molecular Diagnostics: JMD
https://read.qxmd.com/read/35729214/detection-and-characterization-of-latency-stage-of-ebv-and-histopathological-analysis-of-prostatic-adenocarcinoma-tissues
#26
JOURNAL ARTICLE
Khalid Ahmed, Alisalman Sheikh, Saira Fatima, Ghulam Haider, Kulsoom Ghias, Farhat Abbas, Nouman Mughal, Syed Hani Abidi
The pathophysiology of prostate cancer involves both genetic and acquired factors, including pathogens, such as viruses. A limited number of studies have shown the presence of Epstein-Barr virus (EBV) in prostate cancer tissues. However, there is a dearth of data exploring EBV latency profile in prostate cancer, and the relationship of EBV with histopathological features of prostate cancer. In this study, prostate cancer and benign prostatic hyperplasia (BPH) samples were screened for the presence of EBV, followed by the characterization of the EBV latency profile and analysis of histopathological parameters in EBV-positive and EBV-negative groups...
June 21, 2022: Scientific Reports
https://read.qxmd.com/read/35577732/the-accuracy-of-sequential-urethral-frozen-section-and-its-impact-on-urethral-recurrence-after-radical-cystectomy
#27
JOURNAL ARTICLE
Georgios Gakis, Manuel Alexander Schmid, Fahmy Hassan, Arnulf Stenzl, Markus Renninger
OBJECTIVE: To assess the accuracy of frozen section analysis (FSA) for detecting and eliminating malignant urethral margins during radical cystectomy (RC) for bladder cancer (BC) and its impact on urethral recurrence. METHODS: Urethral margins were initially examined by FSA in 217 patients at RC. When positive, additional resections were performed. Subsequently, all specimens were re-examined on formalin-fixed, paraffin-embedded sections (FFPE). Malignancy was defined as either the presence of carcinoma in situ, high-grade or invasive tumor cells at the urethral margin...
April 22, 2022: Clinical Genitourinary Cancer
https://read.qxmd.com/read/35556601/spatial-whole-transcriptome-profiling-of-the-tumor-microenvironment-in-prostate-carcinomas
#28
JOURNAL ARTICLE
Dan Walker, Valeria Giangarra, Naishitha Anaparthy, Stephen Williams, Jyoti Sheldon, Mesruh Turkekul, Paulius Mielinis, Caroline Gallant, James Chell, Sarah Taylor
BACKGROUND: Despite years of studies and effort, the best strategies for treating prostate cancer and minimizing the complications of treatment remain unanswered questions. This gap in knowledge is partially due to the inability to dissect the complex heterogeneous tumor microenvironment (TME) and immune compartment. Spatially resolved molecular profiling of tumor sections will enhance our understanding of these complexities; However, it has been particularly challenging to do spatial molecular profiling in formalin-fixed paraffin-embedded (FFPE) tissues due to RNA degradation associated with this tissue-embedding method, which is routinely used in oncology workflows...
May 2022: FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology
https://read.qxmd.com/read/35527349/urinary-extracellular-vesicles-contain-mature-transcriptome-enriched-in-circular-and-long-noncoding-rnas-with-functional-significance-in-prostate-cancer
#29
JOURNAL ARTICLE
Anna Almeida, Marc Gabriel, Virginie Firlej, Lorena Martin-Jaular, Matthieu Lejars, Rocco Cipolla, Floriane Petit, Nicolas Vogt, Mabel San-Roman, Florent Dingli, Damarys Loew, Damien Destouches, Francis Vacherot, Alexandre de la Taille, Clotilde Théry, Antonin Morillon
Long noncoding (lnc)RNAs modulate gene expression alongside presenting unexpected source of neoantigens. Despite their immense interest, their ability to be transferred and control adjacent cells is unknown. Extracellular Vesicles (EVs) offer a protective environment for nucleic acids, with pro and antitumourigenic functions by controlling the immune response. In contrast to extracellular nonvesicular RNA, few studies have addressed the full RNA content within human fluids' EVs and have compared them with their tissue of origin...
May 2022: Journal of Extracellular Vesicles
https://read.qxmd.com/read/35468339/distinct-expression-signatures-of-mir-130a-mir-301a-mir-454-in-formalin-fixed-paraffin-embedded-tissue-samples-of-prostate-cancer-patients
#30
JOURNAL ARTICLE
Esra Bozgeyik, Onur Ceylan
Recent advances in high-throughput screening of human tumors have enabled the identification of numerous tumor markers. However, the clinical utility of these newly identified molecules remains enigmatic until they are well validated in patient samples. Although many long non-coding RNA molecules of clinical importance have been identified in the differential diagnosis of prostate cancer, the consistency of many of them in practice is still controversial. Therefore, short non-coding RNA molecules such as miRNAs are coming to the forefront in the differential diagnosis of the disease because of their stability...
June 2022: Pathology, Research and Practice
https://read.qxmd.com/read/35459777/automated-quantitative-high-throughput-multiplex-immunofluorescence-pipeline-to-evaluate-oxphos-defects-in-formalin-fixed-human-prostate-tissue
#31
JOURNAL ARTICLE
Ashwin Sachdeva, Claire A Hart, Christopher D Carey, Amy E Vincent, Laura C Greaves, Rakesh Heer, Pedro Oliveira, Michael D Brown, Noel W Clarke, Doug M Turnbull
Advances in multiplex immunofluorescence (mIF) and digital image analysis has enabled simultaneous assessment of protein defects in electron transport chain components. However, current manual methodology is time consuming and labour intensive. Therefore, we developed an automated high-throughput mIF workflow for quantitative single-cell level assessment of formalin fixed paraffin embedded tissue (FFPE), leveraging tyramide signal amplification on a Ventana Ultra platform coupled with automated multispectral imaging on a Vectra 3 platform...
April 22, 2022: Scientific Reports
https://read.qxmd.com/read/35384248/evaluation-of-the-therapeutic-potential-of-masitinib-and-expression-of-its-specific-targets-c-kit-pdgfr-%C3%AE-pdgfr-%C3%AE-and-lyn-in-canine-prostate-cancer-cell-lines
#32
JOURNAL ARTICLE
Katharina Klose, Eva-Maria Packeiser, José-Luis Granados-Soler, Marion Hewicker-Trautwein, Hugo Murua Escobar, Ingo Nolte
Canine prostate cancer is classified into adenocarcinoma, transitional cell carcinoma with prostatic involvement, and mixed forms. Early metastatic spread leads to poor prognosis and limited treatment options. Masitinib is approved for the treatment of canine mast cell tumours and inhibits tyrosine kinase c-Kit, tyrosine-protein kinase Lyn (Lyn), and platelet-derived growth factor receptors alpha and beta (PDGFR-α, PDGFR-β), which are known to be expressed in canine prostate cancer. The aim of this study was to evaluate masitinib in an in vitro model consisting of cell lines from primary prostate adenocarcinoma, the associated lymph node metastasis of the same patient, and transitional cell carcinoma...
September 2022: Veterinary and Comparative Oncology
https://read.qxmd.com/read/34885151/proteomic-analysis-identifies-ndufs1-and-atp5o-as-novel-markers-for-survival-outcome-in-prostate-cancer
#33
JOURNAL ARTICLE
Robert Wiebringhaus, Matteo Pecoraro, Heidi A Neubauer, Karolína Trachtová, Bettina Trimmel, Maritta Wieselberg, Jan Pencik, Gerda Egger, Christoph Krall, Richard Moriggl, Matthias Mann, Brigitte Hantusch, Lukas Kenner
We aimed to identify novel markers for aggressive prostate cancer in a STAT3-low proteomics-derived dataset of mitochondrial proteins by immunohistochemical analysis and correlation with transcriptomic data and biochemical recurrence in a STAT3 independent PCa cohort. Formalin-fixed paraffin-embedded tissue (FFPE) sample selection for proteomic analysis and tissue-microarray (TMA) generation was conducted from a cohort of PCa patients. Retrospective data analysis was performed with the same cohort. 153 proteins differentially expressed between STAT3-low and STAT3-high samples were identified...
November 30, 2021: Cancers
https://read.qxmd.com/read/34799972/a-prostate-cancer-tissue-specific-spectral-library-for-targeted-proteomic-analysis
#34
JOURNAL ARTICLE
Rui Sun, Mengge Lyu, Shuang Liang, Weigang Ge, Yingrui Wang, Xuan Ding, Cheng Zhang, Yan Zhou, Shanjun Chen, Lirong Chen, Tiannan Guo
Prostate cancer is the most common cancer in males worldwide. Mass spectrometry-based targeted proteomics has demonstrated great potential in quantifying proteins from formalin-fixed paraffin-embedded (FFPE) and (fresh) frozen biopsy tissues. Here we provide a comprehensive tissue-specific spectral library for targeted proteomic analysis of prostate tissue samples. Benign and malignant FFPE prostate tissue samples were processed into peptide samples by pressure cycling technology (PCT)-assisted sample preparation, and fractionated with high-pH reversed phase liquid chromatography (RPLC)...
April 2022: Proteomics
https://read.qxmd.com/read/34788144/multiple-origin-and-tumor-heterogeneity-of-prostatic-ductal-adenocarcinoma-in-the-han-chinese-population
#35
JOURNAL ARTICLE
Wei Zhang, Fei Su, Miao Wang, Huimin Hou, Ming Liu, Dongge Liu, Honggang Liu
Purpose: Prostatic ductal adenocarcinoma (PDA) is recognized as an advanced stage cancer and is often observed in conjunction with acinar adenocarcinoma, with abundant cytoplasm arranged in a papillary pattern. When compared with acinar adenocarcinoma, it is characterized by an increased biochemical recurrence rate and unusual metastasis sites. The purpose of the present study was to further elucidate the genomic alterations associated with PDA. Methods: Whole-exome sequencing (WES) and linkage analyses were performed on genomic DNA isolated from formalin-fixed, paraffin-embedded (FFPE) samples obtained from eleven PDA tumors and paired benign tissues...
November 2021: Genetic Testing and Molecular Biomarkers
https://read.qxmd.com/read/34454584/longitudinal-analysis-of-individual-cfdna-methylome-patterns-in-metastatic-prostate-cancer
#36
JOURNAL ARTICLE
Romina Silva, Bruce Moran, Anne-Marie Baird, Colm J O'Rourke, Stephen P Finn, Ray McDermott, William Watson, William M Gallagher, Donal J Brennan, Antoinette S Perry
BACKGROUND: Disease progression and therapeutic resistance are hallmarks of advanced stage prostate cancer (PCa), which remains a major cause of cancer-related mortality around the world. Longitudinal studies, coupled with the use of liquid biopsies, offer a potentially new and minimally invasive platform to study the dynamics of tumour progression. Our aim was to investigate the dynamics of personal DNA methylomic profiles of metastatic PCa (mPCa) patients, during disease progression and therapy administration...
August 28, 2021: Clinical Epigenetics
https://read.qxmd.com/read/34362692/molecular-subtypes-and-gene-expression-signatures-as-prognostic-features-in-fully-resected-clear-cell-renal-cell-carcinoma-a-tailored-approach-to-adjuvant-trials
#37
JOURNAL ARTICLE
Eduard Roussel, Annelies Verbiest, Lisa Kinget, Bram Boeckx, Jessica Zucman-Rossi, Gabrielle Couchy, Stefano Caruso, Sylvie Job, Aurélien de Reyniès, Liesbeth De Wever, Marcella Baldewijns, Hendrik Van Poppel, Steven Joniau, Diether Lambrechts, Maarten Albersen, Benoit Beuselinck
BACKGROUND: Trials with adjuvant vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) failed to demonstrate meaningful benefit in clinically high-risk, fully resected clear cell renal cell carcinoma (ccRCC). We evaluated whether the ccrcc1-4 molecular subtypes and gene expression signatures (GES) are associated with outcomes in this setting. MATERIALS AND METHODS: We determined molecular subtypes as well as angiogenesis- and immune-related GES through RNA sequencing of 75 fresh frozen (FF) and 62 formalin-fixed, paraffin-embedded (FFPE) tumor samples...
December 2021: Clinical Genitourinary Cancer
https://read.qxmd.com/read/34277455/investigation-of-neural-microenvironment-in-prostate-cancer-in-context-of-neural-density-perineural-invasion-and-neuroendocrine-profile-of-tumors
#38
JOURNAL ARTICLE
Dawid Sigorski, Jacek Gulczyński, Aleksandra Sejda, Wojciech Rogowski, Ewa Iżycka-Świeszewska
BACKGROUND: Cancer stroma contains the neural compartment with specific components and action. Neural microenvironment processing includes among others axonogenesis, perineural invasion (PNI), neurosignaling, and tumor cell neural/neuroendocrine differentiation. Growing data suggest that tumor-neural crosstalk plays an important function in prostate cancer (PCa) biology. However, the mechanisms involved in PNI and axonogenesis, as well as their patho-clinical correlations in this tumor are unclear...
2021: Frontiers in Oncology
https://read.qxmd.com/read/34157052/clinicopathological-significance-of-the-emt-related-proteins-and-their-interrelationships-in-prostate-cancer-an-immunohistochemical-study
#39
JOURNAL ARTICLE
Martyna Parol-Kulczyk, Arkadiusz Gzil, Joanna Maciejewska, Magdalena Bodnar, Dariusz Grzanka
The chronic inflammation influences a microenvironment, where as a result of losing control over tissue homeostatic mechanisms, the carcinogenesis process may be induced. Inflammatory response cells can secrete a number of factors that support both initiation and progression of cancer and also they may consequently induct an epithelial-mesenchymal transition (EMT), the process responsible for development of distant metastasis. Macrophage migration inhibitory factor (MIF) acts as a pro-inflammatory cytokine that is considered as a link between chronic inflammation and tumor development...
2021: PloS One
https://read.qxmd.com/read/33948855/differentially-expressed-mir-20-mir-21-mir-100-mir-125a-and-mir-146a-as-a-potential-biomarker-for-prostate-cancer
#40
JOURNAL ARTICLE
Mohan Damodaran, Mohanapriya Chinambedu Dandapani, SimonDuraiRaj, SandhyaSundaram, S VenkatRamanan, Ilangovan Ramachandran, Vettriselvi Venkatesan
Prostate cancer is the leading cause of death among men worldwide. Deregulation of microRNAs has been reported in many cancers. Expression of microRNAs miR-20a-5p, miR-21-5p, miR-100-5p, miR-125a-5p and miR-146a-5p in tissue blocks of histologically confirmed prostate cancer patients compared with BPH patients, to identify potential microRNA biomarker for prostate cancer. MicroRNA was isolated and expression was quantified by qRT-PCR using Taqman Advanced microRNA assay kits. The interactions between the microRNA:target mRNA were predicted by using bioinformatics tools such as miRwalk and miRTargetlink...
April 2021: Molecular Biology Reports
keyword
keyword
104318
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.